This category covers the systems and protocols used to generate antibodies at different scales. Topics include expression hosts, purification strategies, and quality control measures.
Identifying the right antigen is the first step in therapeutic antibody development. Biointron outlines methods that guide discovery and advance drug pipelines.
Biointron streamlines antibody production and purification, applying recombinant expression, hybridoma methods, and chromatography techniques to ensure purity and performance.
From hybridoma to recombinant platforms, Biointron leads innovations in antibody production and engineering, enabling faster, more flexible, and reliable research solutions.
Explore ethical questions around antibody production in animals, the 3Rs principle, and how recombinant technology reduces animal use while ensuring high-quality science.
You can also contact us on the Scientist and Science Exchange marketplaces.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
